Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis.
about
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.Inhibiting Skp2 E3 Ligase Suppresses Bleomycin-Induced Pulmonary Fibrosis.Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis.Bleomycin Revisited: A Direct Comparison of the Intratracheal Micro-Spraying and the Oropharyngeal Aspiration Routes of Bleomycin Administration in MiceThe Development of Serum Amyloid P as a Possible Therapeutic
P2860
Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis.
@en
type
label
Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis.
@en
prefLabel
Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis.
@en
P2093
P2860
P356
P1476
Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis
@en
P2093
Andrew H Limper
Argyrios Tzouvelekis
Gustavo A Rubio
Ioanna Ninou
Kurt Williams
Marilyn K Glassberg
Sharon J Elliot
Vassilis Aidinis
P2860
P356
10.3389/FMED.2017.00118
P50
P577
2017-07-28T00:00:00Z